LYTIR

Insider · SEC Form 4 · Chief Financial Officer

Adam Taich

Filed with the SEC as Taich Adam; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $4.1M of TXG. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $4.1M in total.Aug: Insider sales $1.1MSep: Insider sales $3.0MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $4.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. TXGSold: 10x Genomics, Inc. Sep 9, 2026 46,388 shares filed Sep 11, 2026 3 transactions 10b5-1 plan filing $3.0M
  2. TXGSold: 10x Genomics, Inc. Aug 24, 2026 17,166 shares filed Aug 26, 2026 362,732 shares held directly after, as filed filing $1.1M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.